Understanding liver fibrosis and cirrhosis

Pathobiology of hepatic fibrosis and cirrhosis

NIH-funded research Ralph H Johnson VA Medical Center · NIH-10911032

This study is looking at how liver damage can lead to scarring, called fibrosis, and how certain cells in the liver change and contribute to this process, with the hope of finding new ways to treat liver diseases that could help patients like you.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionRalph H Johnson VA Medical Center NIH-funded
Lab location1 site (Charleston, United States)
Project IDNIH-10911032 on NIH RePORTER

What this research studies

This research investigates how liver fibrosis develops as a response to chronic liver injury, leading to cirrhosis and its serious complications. It focuses on the role of hepatic stellate cells, which transform into myofibroblasts and contribute to the production of extracellular matrix proteins that cause fibrosis. By exploring the mechanisms behind this transformation and the actin cytoskeleton's involvement, the research aims to identify potential therapeutic targets to inhibit fibrosis. Patients may benefit from insights that could lead to new treatments for liver diseases.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with chronic liver injury or conditions leading to liver fibrosis.

Not a fit: Patients with acute liver injury or those without any liver disease may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that prevent or reverse liver fibrosis and cirrhosis, improving patient outcomes.

How similar studies have performed: Previous research has shown promising results in understanding the mechanisms of fibrosis in other organs, suggesting potential for success in this area as well.

Where this research is happening

Charleston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.